Education

Bone Club Webinar series

Three-Part Webinar Series

Join SIO for an intermediate-level (200) musculoskeletal (MSK) three-part webinar series. Part one will focus on the interventional treatment of malignant and metastatic bone lesions in both the axial and appendicular skeleton, covering fixation techniques like ablation, cementation, and embolization. Part two will focus on the finer details of patient evaluation and procedural techniques for benign bone lesions, demonstrating bone grafting for UBC/ABC. Part three addresses the general guidelines and physiology for the management of oncologic pain using cryoneurolysis, techniques for managing chest wall masses and ablative options for management of aggressive pelvic disease tumors.

To get the most out of the series, we recommend registering for all three sessions.

Part 1: How I Do It—From Imaging Workup to Intervention: Metastatic/Malignant Bone Lesions

Wednesday, 24 September 2025 | 7 – 8:30 p.m. ET

Faculty

Moderator

Gina Landinez, MD

Baptist Health South Florida, Miami Cadiac and Vascular Institute

Faculty Panel

Jason Levy MD, FSIR

Northside Radiology Associates

Marwan Moussa, MD

Beth Israel Deaconess Medical Center

Brandon Key, MD

Froedtert & Medical College of Wisconsin

Watch On-Demand

Part 2: How I Do It—From Imaging Workup to Intervention: Benign MSK Lesions

Wednesday, 8 October 2025 | 7 – 8:30 p.m. ET

Faculty

Moderator

Thedore Vander Velde, MD

Mallinckrodt Institute of Radiology

Faculty Panel

James Murakami, MD, MS

Nationwide Children's Hospital

Shankar Rajeswaran, MD

Northwestern University

Eric Monroe, MD

University of Wisconsin

Watch On-Demand

Part 3: How I Do It—From Imaging Workup to Intervention: Cryoneurolysis for Pain

Tuesday, 11 November 2025 | 7 – 8:30 p.m. ET

Faculty

Moderator

Sirish Kishore, MD

Stanford University

Faculty Panel

Junjian Huang, MD

Emory Healthcare

Shantanu Warhadpande MD

University of Michigan

John David Prologo, MD

Emory Healthcare

Register Now

The Bone Club webinar series is supported by:

HCC Webinar Series

Join SIO for a three-part webinar series on hepatocellular carcinoma (HCC) this fall. Part one will cover advances in treatment with a shift toward combination therapies and sequencing strategies to optimize patient outcomes. Part two will explore the role of immunotherapy in HCC, including combinations with locoregional therapies, mechanisms of resistance, biomarker predictions and other therapeutic targets. Part three will highlight ongoing critical trials of combination locoregional therapy and immunotherapy in the liver.

To get the most out of the series, we recommend registering for all three sessions.

Part 1: Advancing HCC Treatment: Sequencing Strategies and Managing Combination Therapies

Tuesday, 30 September 2025 | 7:00–8:00 p.m. ET

Faculty

Moderator

Julius Chapiro, MD, PhD

Yale University

Faculty Panel

Richard Finn, MD

University of California Los Angeles

Nicholas Fidelman, MD

University of California San Francisco

Watch On-Demand

Part 2: Integrating Immunotherapy with Locoregional Therapies in HCC: Mechanisms, Biomarkers, and Resistance

Wednesday, 22 October 2025 | 7:00–8:00 p.m. ET

Faculty

Moderator

Julius Chapiro, MD, PhD

Yale University

Faculty Panel

Terence Gade, MD, PhD

University of Pennsylvania

Sarah Manes

Global Liver Institute

Anjana Pillai, MD

University of Chicago

Michael Soulen, MD, FSIR, FCIRSE

University of Pennsylvania

Register Now

Part 3: Ongoing Critical Trials of Combination Locoregional Therapy and Immunotherapy in the Liver

Tuesday, 4 November 2025 | 7:00–8:30 p.m. ET

This webinar is sponsored by:

Faculty

Moderator

Zach Berman, MD

UC San Diego

Faculty Panel

Adam Burgoyne, MD, PhD

UC San Diego

Kirema Garcia-Reyes, MD

Mount Sinai

Christopher Malone, MD

Washington University

Register Now

The HCC webinar series is sponsored by:

CCF Webinar: Navigating Cholangiocarcinoma - A Patient's Journey with Interventional Oncology

SIO is proud to partner with the Cholangiocarcinoma Foundation for a compelling webinar featuring renowned interventional oncologists Christos Georgiades, MD, PhD, and Sarah White, MD, MS, FSIR, and cholangiocarcinoma patient, Lynn Lazzaro. Together, they explore how interventional oncology (IO) treatments, combined with a multidisciplinary team (MDT) approach, played a pivotal role in Lynn’s care. Discover the innovative techniques and compassionate care that have made a difference in Lynn's life and learn how interventional oncology can offer hope and effective solutions for complex cancer cases.

Faculty

Christos Georgiades, MD, PhD

Johns Hopkins Medicine

Lynn Statz Lazzaro, CPA, CFP, MST

Sarah White, MD, MS, FSIR, FCIRSE

Medical College of Wisconsin

Watch On-Demand

This webinar is in partnership with the Cholangiocarcinoma Foundation

Meet The Data Podcast

Conversations with Leading Experts on HCC and Immunotherapy

Coming later this month, SIO is launching a four-part podcast series featuring discussions on pivotal trials that established immunotherapy’s role in advanced HCC. Supported by an educational grant from AstraZeneca.

Bone Club Webinar series

Part 1: How I Do It—From Imaging Workup to Intervention: Metastatic/Malignant Bone Lesions

Faculty

Moderator

Gina Landinez, MD

Faculty Panel

Jason Levy MD, FSIR

Marwan Moussa, MD

Brandon Key, MD

Part 2: How I Do It—From Imaging Workup to Intervention: Benign MSK Lesions

Faculty

Moderator

Thedore Vander Velde, MD

Faculty Panel

James Murakami, MD, MS

Shankar Rajeswaran, MD

Eric Monroe, MD

Part 3: How I Do It—From Imaging Workup to Intervention: Cryoneurolysis for Pain

Faculty

Moderator

Sirish Kishore, MD

Faculty Panel

Junjian Huang, MD

Shantanu Warhadpande MD

John David Prologo, MD

HCC Webinar Series

Part 1: Advancing HCC Treatment: Sequencing Strategies and Managing Combination Therapies

Faculty

Moderator

Julius Chapiro, MD, PhD

Faculty Panel

Richard Finn, MD

Nicholas Fidelman, MD

Part 2: Integrating Immunotherapy with Locoregional Therapies in HCC: Mechanisms, Biomarkers, and Resistance

Faculty

Moderator

Julius Chapiro, MD, PhD

Faculty Panel

Terence Gade, MD, PhD

Sarah Manes

Anjana Pillai, MD

Michael Soulen, MD, FSIR, FCIRSE

Part 3: Ongoing Critical Trials of Combination Locoregional Therapy and Immunotherapy in the Liver

Faculty

Moderator

Zach Berman, MD

Faculty Panel

Adam Burgoyne, MD, PhD

Kirema Garcia-Reyes, MD

Christopher Malone, MD

CCF Webinar: Navigating Cholangiocarcinoma - A Patient's Journey with Interventional Oncology

Faculty

Christos Georgiades, MD, PhD

Lynn Statz Lazzaro, CPA, CFP, MST

Sarah White, MD, MS, FSIR, FCIRSE

Meet The Data Podcast

Conversations with Leading Experts on HCC and Immunotherapy

HCC Focus

Immunotherapy

Expert Insights